SVA Financials
Sinovac Biotech Ltd - Financial statements & key metrics
Stock Price
$6.47
Market Cap
$642.44M
P/E Ratio
6.7
EPS
$0.97
Income Statement Highlights
Most Recent Quarter: 2023-12-31
Revenue
$448.27M
Gross Profit
$266.75M
Operating Income
$-546.72M
Net Income
$-99.92M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$13.66B
Total Liabilities
$1.64B
Shareholders Equity
$8.71B
Cash & Equivalents
$1.27B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$106.02M
CapEx
$145.69M
Free Cash Flow
$-39.67M
Profitability Metrics
Gross Margin
86.8%
Operating Margin
0.4%
Net Margin
0.2%
ROE
0.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SVA revenue?
SVA's most recent quarterly revenue was $448.27M. Annual revenue can be calculated by summing the four most recent quarters.
Is SVA profitable?
SVA reported a loss of $99.92M in the most recent quarter. The net profit margin is 0.2%.
What is SVA market cap?
SVA has a market capitalization of $642.44M, making it a small-cap stock.
Does SVA have debt?
View SVA's balance sheet for debt information.
What is SVA cash flow?
SVA's most recent quarterly free cash flow was $-39.67M.